Talkspace (TALK) Competitors $3.16 +0.07 (+2.27%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TALK vs. WGS, USPH, PNTG, INNV, SHCR, DCGO, EUDA, PIII, ATPC, and KDLYShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include GeneDx (WGS), U.S. Physical Therapy (USPH), The Pennant Group (PNTG), InnovAge (INNV), Sharecare (SHCR), DocGo (DCGO), EUDA Health (EUDA), P3 Health Partners (PIII), Agape ATP (ATPC), and Kindly MD (KDLY). These companies are all part of the "health services" industry. Talkspace vs. GeneDx U.S. Physical Therapy The Pennant Group InnovAge Sharecare DocGo EUDA Health P3 Health Partners Agape ATP Kindly MD Talkspace (NASDAQ:TALK) and GeneDx (NASDAQ:WGS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations, community ranking and media sentiment. Does the MarketBeat Community favor TALK or WGS? GeneDx received 9 more outperform votes than Talkspace when rated by MarketBeat users. Likewise, 47.62% of users gave GeneDx an outperform vote while only 12.50% of users gave Talkspace an outperform vote. CompanyUnderperformOutperformTalkspaceOutperform Votes112.50%Underperform Votes787.50% GeneDxOutperform Votes1047.62% Underperform Votes1152.38% Which has better earnings and valuation, TALK or WGS? Talkspace has higher earnings, but lower revenue than GeneDx. Talkspace is trading at a lower price-to-earnings ratio than GeneDx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalkspace$150.04M3.56-$19.18M-$0.01-316.00GeneDx$267.23M7.13-$175.77M-$3.11-22.31 Is TALK or WGS more profitable? Talkspace has a net margin of -0.76% compared to GeneDx's net margin of -31.25%. Talkspace's return on equity of -1.17% beat GeneDx's return on equity.Company Net Margins Return on Equity Return on Assets Talkspace-0.76% -1.17% -0.99% GeneDx -31.25%-13.35%-6.91% Does the media refer more to TALK or WGS? In the previous week, GeneDx had 9 more articles in the media than Talkspace. MarketBeat recorded 17 mentions for GeneDx and 8 mentions for Talkspace. Talkspace's average media sentiment score of 0.74 beat GeneDx's score of 0.44 indicating that Talkspace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talkspace 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GeneDx 8 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in TALK or WGS? 57.4% of Talkspace shares are held by institutional investors. Comparatively, 61.7% of GeneDx shares are held by institutional investors. 21.7% of Talkspace shares are held by company insiders. Comparatively, 27.3% of GeneDx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, TALK or WGS? Talkspace has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, GeneDx has a beta of 2.11, indicating that its share price is 111% more volatile than the S&P 500. Do analysts recommend TALK or WGS? Talkspace presently has a consensus target price of $4.00, indicating a potential upside of 26.58%. GeneDx has a consensus target price of $59.33, indicating a potential downside of 14.48%. Given Talkspace's higher possible upside, equities research analysts plainly believe Talkspace is more favorable than GeneDx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talkspace 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33GeneDx 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryGeneDx beats Talkspace on 11 of the 18 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$521.97M$618.65M$5.05B$8.87BDividend YieldN/A1.94%4.97%4.06%P/E Ratio-316.0031.9997.3414.18Price / Sales3.564.111,218.4289.42Price / CashN/A25.4633.5132.79Price / Book4.512.755.805.12Net Income-$19.18M-$10.72M$119.07M$225.99M7 Day Performance-0.32%-1.16%-1.83%-1.32%1 Month Performance12.46%-2.51%-3.64%0.60%1 Year Performance68.98%387.32%31.62%26.23% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace3.8094 of 5 stars$3.16+2.3%$4.00+26.6%+66.3%$521.97M$150.04M-316.00472Analyst ForecastGap UpWGSGeneDx1.1554 of 5 stars$69.38-2.3%$59.33-14.5%+4,891.4%$1.91B$267.23M-22.311,200Insider TradeNews CoverageUSPHU.S. Physical Therapy2.2759 of 5 stars$94.17+3.9%$105.00+11.5%+9.4%$1.37B$604.80M100.186,720PNTGThe Pennant Group3.6148 of 5 stars$30.78-3.2%$38.25+24.3%+126.2%$1.09B$544.89M45.275,791INNVInnovAge1.4851 of 5 stars$4.70-1.7%$6.50+38.3%-19.0%$647.48M$763.85M0.002,350Gap UpSHCRSharecareN/A$1.43flat$1.43N/A$531.79M$445.25M-3.673,352DCGODocGo1.6705 of 5 stars$4.10+2.0%$6.10+48.8%-28.9%$410.24M$624.29M14.644,164EUDAEUDA Health0.1736 of 5 stars$4.38+0.9%N/A+284.2%$106.88M$3.71M0.002PIIIP3 Health Partners3.2506 of 5 stars$0.20-4.7%$2.38+1,065.4%-82.9%$75.44M$1.27B0.00500Analyst ForecastAnalyst RevisionHigh Trading VolumeATPCAgape ATP0.0129 of 5 stars$1.44+2.9%N/A-92.4%$5.74M$1.35M-1.9740KDLYKindly MDN/A$0.91+9.6%N/AN/A$4.95MN/A0.00N/AGap Up Related Companies and Tools Related Companies GeneDx Competitors U.S. Physical Therapy Competitors The Pennant Group Competitors InnovAge Competitors Sharecare Competitors DocGo Competitors EUDA Health Competitors P3 Health Partners Competitors Agape ATP Competitors Kindly MD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TALK) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
